Back to Agenda
Session 1: Strategy and Regulatory Science of Non-Clinical Development
Session Chair(s)
Chang Won Park
Deputy Director, NIFDS, Korea, Republic of
Speaker(s)
Jung-Shin Park, PhD, RPh
Head of Drug Development Business Unit, SK Biopharmaceuticals, Korea, Republic of
Strategy on Non-Clinical Development of CNS Drugs
Yangmee Shin, PhD
Sr. Pharmacologist, KWiSE, United States
Nonclinical Development Of Anticancer And Pediatric Drugs: A Regulatory Perspective
Have an account?
